This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Kidney function loss and albuminuria progression with GLP-1 receptor agonists versus basal insulin in patients with type 2 diabetes: real-world evidence.
Cardiovascular diabetology, 22(1), 126
Citation
Schechter, Meir; Melzer Cohen, Cheli; Fishkin, Alisa; Rozenberg, Aliza; Yanuv, Ilan; Sehtman-Shachar, Dvora R; Chodick, Gabriel; Clark, Alice; Abrahamsen, Trine J; Lawson, Jack; Karasik, Avraham; Mosenzon, Ofri. (2023). Kidney function loss and albuminuria progression with GLP-1 receptor agonists versus basal insulin in patients with type 2 diabetes: real-world evidence.. Cardiovascular diabetology, 22(1), 126. https://doi.org/10.1186/s12933-023-01829-0